Here's how DOI.ORG makes money* and how much!

*Please read our disclaimer before using our estimates.
Loading...

DOI . ORG {}

  1. Analyzed Page
  2. Matching Content Categories
  3. CMS
  4. Monthly Traffic Estimate
  5. How Does Doi.org Make Money
  6. Keywords
  7. Topics
  8. Questions
  9. Schema
  10. Social Networks
  11. External Links
  12. Analytics And Tracking
  13. Libraries
  14. Hosting Providers
  15. CDN Services

We began analyzing https://www.nature.com/articles/6605486, but it redirected us to https://www.nature.com/articles/6605486. The analysis below is for the second page.

Title[redir]:
Hypoxia potentiates Notch signaling in breast cancer leading to decreased E-cadherin expression and increased cell migration and invasion | British Journal of Cancer
Description:
Epithelial-to-mesenchymal transition (EMT) is associated with decreased adhesion and acquisition of metastatic potential of breast cancer cells. Epithelial-to-mesenchymal transition is mediated, in part, by two transcription repressors, Snail and Slug, that are known to be targets of the Notch signaling pathway, and JAGGED1-induced Notch activation increases EMT. However, the events that lead to increased Notch activity during EMT of breast cancer cells are unknown. The accumulation of hypoxia inducible factors (HIFs) under hypoxia was detected by western blot analysis, and their effects on Notch signaling were measured by an in vitro Notch reporter assay. The expression of Notch target genes under hypoxia was tested by real-time PCR. The knockdown of HIF-1α was mediated by retroviral delivery of shRNA. The expression of Slug and Snail under hypoxia was measured by real-time PCR. Breast cancer cell migration and invasion under hypoxia were tested with cell migration and invasion kits. Hypoxia increased the expression of Notch target genes such as HES1 and HEY1 in breast cancer cells, as was expression of Notch receptors and ligands. The mechanism is likely to involve the accumulation of HIF-1α and HIF-2α in these cells by hypoxia, which synergised with the Notch co-activator MAML1 in potentiating Notch activity. Hypoxia inducible factor-1α was found to bind to HES1 promoter under hypoxia. Knockdown of HIF-1α with shRNA inhibited both HES1 and HEY1 expression under hypoxia. Hypoxia increased the expression of Slug and Snail, and decreased the expression of E-cadherin, hallmarks of EMT. Notch pathway inhibition abrogated the hypoxia-mediated increase in Slug and Snail expression, as well as decreased breast cancer cell migration and invasion. Hypoxia-mediated Notch signaling may have an important role in the initiation of EMT and subsequent potential for breast cancer metastasis.

Matching Content Categories {📚}

  • Science
  • Education
  • Health & Fitness

Content Management System {📝}

What CMS is doi.org built with?

Custom-built

No common CMS systems were detected on Doi.org, and no known web development framework was identified.

Traffic Estimate {📈}

What is the average monthly size of doi.org audience?

🏙️ Massive Traffic: 50M - 100M visitors per month


Based on our best estimate, this website will receive around 80,479,999 visitors per month in the current month.

check SE Ranking
check Ahrefs
check Similarweb
check Ubersuggest
check Semrush

How Does Doi.org Make Money? {💸}

The income method remains a mystery to us.

Not all websites focus on profit; some are designed to educate, connect people, or share useful tools. People create websites for numerous reasons. And this could be one such example. Doi.org might be plotting its profit, but the way they're doing it isn't detectable yet.

Keywords {🔍}

notch, cells, cancer, hypoxia, expression, breast, cell, hifα, signaling, article, figure, google, scholar, cas, hes, increased, human, ecadherin, mda, mcf, snail, maml, emt, invasion, hey, slug, promoter, gsi, nature, migration, activation, mammary, antibody, culture, usa, treatment, analysis, pathway, pcr, conditions, binding, inducible, target, jagged, cultured, assay, genes, realtime, abrogated, metastasis,

Topics {✒️}

nature portfolio privacy policy advertising nature 449 nature 392 nature 451 nature author information authors invasion kits 0/ reprints notch/hif/maml1 immuno-complex initiative event resulting icn3-induced notch signaling regulates notch signaling human ras-transformed cells warm serum-free media ligand-induced notch signaling inhibits hras1-induced oncogenesis hypoxia inducible factor-1α hrp-conjugated secondary antibodies author correspondence dana-farber cancer institute notch1-induced mammary tumorigenesis ligand-mediated notch activation rbp-jκ-binding sites rbp-jκ binding sites real-time pcr analysis published pathway figures zinc-finger proteins snail mouse mammary epithelium cell–cell adhesion molecule hypoxia-mediated notch signaling pre-existing notch signaling real-time pcr experiments induces mammary tumors notch-dependent mechanism hif-1α transcription complex hif-2α potentiated icn1 mouse mammary tumor scratch wound-healing assay low oxygen content antibodies pcdna3/hif-1α full size image notch intracellular domain breast cancer development hypoxia inducible factor permissions notch signaling induces notch1 intracellular domain human mammary tumourigenesis

Questions {❓}

  • Peinado H, Olmeda D, Cano A (2007) Snail, Zeb and bHLH factors in tumour progression: an alliance against the epithelial phenotype?

Schema {🗺️}

WebPage:
      mainEntity:
         headline:Hypoxia potentiates Notch signaling in breast cancer leading to decreased E-cadherin expression and increased cell migration and invasion
         description:Epithelial-to-mesenchymal transition (EMT) is associated with decreased adhesion and acquisition of metastatic potential of breast cancer cells. Epithelial-to-mesenchymal transition is mediated, in part, by two transcription repressors, Snail and Slug, that are known to be targets of the Notch signaling pathway, and JAGGED1-induced Notch activation increases EMT. However, the events that lead to increased Notch activity during EMT of breast cancer cells are unknown. The accumulation of hypoxia inducible factors (HIFs) under hypoxia was detected by western blot analysis, and their effects on Notch signaling were measured by an in vitro Notch reporter assay. The expression of Notch target genes under hypoxia was tested by real-time PCR. The knockdown of HIF-1α was mediated by retroviral delivery of shRNA. The expression of Slug and Snail under hypoxia was measured by real-time PCR. Breast cancer cell migration and invasion under hypoxia were tested with cell migration and invasion kits. Hypoxia increased the expression of Notch target genes such as HES1 and HEY1 in breast cancer cells, as was expression of Notch receptors and ligands. The mechanism is likely to involve the accumulation of HIF-1α and HIF-2α in these cells by hypoxia, which synergised with the Notch co-activator MAML1 in potentiating Notch activity. Hypoxia inducible factor-1α was found to bind to HES1 promoter under hypoxia. Knockdown of HIF-1α with shRNA inhibited both HES1 and HEY1 expression under hypoxia. Hypoxia increased the expression of Slug and Snail, and decreased the expression of E-cadherin, hallmarks of EMT. Notch pathway inhibition abrogated the hypoxia-mediated increase in Slug and Snail expression, as well as decreased breast cancer cell migration and invasion. Hypoxia-mediated Notch signaling may have an important role in the initiation of EMT and subsequent potential for breast cancer metastasis.
         datePublished:2009-12-15T00:00:00Z
         dateModified:2011-11-16T00:00:00Z
         pageStart:351
         pageEnd:360
         sameAs:https://doi.org/10.1038/sj.bjc.6605486
         keywords:
            Notch
            hypoxia
            hypoxia inducible factor (HIF)
            breast cancer
            epithelial-to-mesenchymal transition (EMT)
            Biomedicine
            general
            Cancer Research
            Epidemiology
            Molecular Medicine
            Oncology
            Drug Resistance
         image:
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1038%2Fsj.bjc.6605486/MediaObjects/41416_2010_Article_BF6605486_Fig1_HTML.jpg
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1038%2Fsj.bjc.6605486/MediaObjects/41416_2010_Article_BF6605486_Fig2_HTML.jpg
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1038%2Fsj.bjc.6605486/MediaObjects/41416_2010_Article_BF6605486_Fig3_HTML.jpg
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1038%2Fsj.bjc.6605486/MediaObjects/41416_2010_Article_BF6605486_Fig4_HTML.jpg
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1038%2Fsj.bjc.6605486/MediaObjects/41416_2010_Article_BF6605486_Fig5_HTML.jpg
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1038%2Fsj.bjc.6605486/MediaObjects/41416_2010_Article_BF6605486_Fig6_HTML.jpg
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1038%2Fsj.bjc.6605486/MediaObjects/41416_2010_Article_BF6605486_Fig7_HTML.jpg
         isPartOf:
            name:British Journal of Cancer
            issn:
               1532-1827
               0007-0920
            volumeNumber:102
            type:
               Periodical
               PublicationVolume
         publisher:
            name:Nature Publishing Group UK
            logo:
               url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
               type:ImageObject
            type:Organization
         author:
               name:J Chen
               affiliation:
                     name:Dana-Farber Cancer Institute
                     address:
                        name:Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, USA
                        type:PostalAddress
                     type:Organization
               type:Person
               name:N Imanaka
               affiliation:
                     name:Dana-Farber Cancer Institute
                     address:
                        name:Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, USA
                        type:PostalAddress
                     type:Organization
               type:Person
               name:J Chen
               affiliation:
                     name:Dana-Farber Cancer Institute
                     address:
                        name:Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, USA
                        type:PostalAddress
                     type:Organization
               type:Person
               name:J D Griffin
               affiliation:
                     name:Dana-Farber Cancer Institute
                     address:
                        name:Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, USA
                        type:PostalAddress
                     type:Organization
               email:[email protected]
               type:Person
         isAccessibleForFree:1
         type:ScholarlyArticle
      context:https://schema.org
ScholarlyArticle:
      headline:Hypoxia potentiates Notch signaling in breast cancer leading to decreased E-cadherin expression and increased cell migration and invasion
      description:Epithelial-to-mesenchymal transition (EMT) is associated with decreased adhesion and acquisition of metastatic potential of breast cancer cells. Epithelial-to-mesenchymal transition is mediated, in part, by two transcription repressors, Snail and Slug, that are known to be targets of the Notch signaling pathway, and JAGGED1-induced Notch activation increases EMT. However, the events that lead to increased Notch activity during EMT of breast cancer cells are unknown. The accumulation of hypoxia inducible factors (HIFs) under hypoxia was detected by western blot analysis, and their effects on Notch signaling were measured by an in vitro Notch reporter assay. The expression of Notch target genes under hypoxia was tested by real-time PCR. The knockdown of HIF-1α was mediated by retroviral delivery of shRNA. The expression of Slug and Snail under hypoxia was measured by real-time PCR. Breast cancer cell migration and invasion under hypoxia were tested with cell migration and invasion kits. Hypoxia increased the expression of Notch target genes such as HES1 and HEY1 in breast cancer cells, as was expression of Notch receptors and ligands. The mechanism is likely to involve the accumulation of HIF-1α and HIF-2α in these cells by hypoxia, which synergised with the Notch co-activator MAML1 in potentiating Notch activity. Hypoxia inducible factor-1α was found to bind to HES1 promoter under hypoxia. Knockdown of HIF-1α with shRNA inhibited both HES1 and HEY1 expression under hypoxia. Hypoxia increased the expression of Slug and Snail, and decreased the expression of E-cadherin, hallmarks of EMT. Notch pathway inhibition abrogated the hypoxia-mediated increase in Slug and Snail expression, as well as decreased breast cancer cell migration and invasion. Hypoxia-mediated Notch signaling may have an important role in the initiation of EMT and subsequent potential for breast cancer metastasis.
      datePublished:2009-12-15T00:00:00Z
      dateModified:2011-11-16T00:00:00Z
      pageStart:351
      pageEnd:360
      sameAs:https://doi.org/10.1038/sj.bjc.6605486
      keywords:
         Notch
         hypoxia
         hypoxia inducible factor (HIF)
         breast cancer
         epithelial-to-mesenchymal transition (EMT)
         Biomedicine
         general
         Cancer Research
         Epidemiology
         Molecular Medicine
         Oncology
         Drug Resistance
      image:
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1038%2Fsj.bjc.6605486/MediaObjects/41416_2010_Article_BF6605486_Fig1_HTML.jpg
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1038%2Fsj.bjc.6605486/MediaObjects/41416_2010_Article_BF6605486_Fig2_HTML.jpg
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1038%2Fsj.bjc.6605486/MediaObjects/41416_2010_Article_BF6605486_Fig3_HTML.jpg
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1038%2Fsj.bjc.6605486/MediaObjects/41416_2010_Article_BF6605486_Fig4_HTML.jpg
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1038%2Fsj.bjc.6605486/MediaObjects/41416_2010_Article_BF6605486_Fig5_HTML.jpg
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1038%2Fsj.bjc.6605486/MediaObjects/41416_2010_Article_BF6605486_Fig6_HTML.jpg
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1038%2Fsj.bjc.6605486/MediaObjects/41416_2010_Article_BF6605486_Fig7_HTML.jpg
      isPartOf:
         name:British Journal of Cancer
         issn:
            1532-1827
            0007-0920
         volumeNumber:102
         type:
            Periodical
            PublicationVolume
      publisher:
         name:Nature Publishing Group UK
         logo:
            url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
            type:ImageObject
         type:Organization
      author:
            name:J Chen
            affiliation:
                  name:Dana-Farber Cancer Institute
                  address:
                     name:Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, USA
                     type:PostalAddress
                  type:Organization
            type:Person
            name:N Imanaka
            affiliation:
                  name:Dana-Farber Cancer Institute
                  address:
                     name:Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, USA
                     type:PostalAddress
                  type:Organization
            type:Person
            name:J Chen
            affiliation:
                  name:Dana-Farber Cancer Institute
                  address:
                     name:Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, USA
                     type:PostalAddress
                  type:Organization
            type:Person
            name:J D Griffin
            affiliation:
                  name:Dana-Farber Cancer Institute
                  address:
                     name:Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, USA
                     type:PostalAddress
                  type:Organization
            email:[email protected]
            type:Person
      isAccessibleForFree:1
["Periodical","PublicationVolume"]:
      name:British Journal of Cancer
      issn:
         1532-1827
         0007-0920
      volumeNumber:102
Organization:
      name:Nature Publishing Group UK
      logo:
         url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
         type:ImageObject
      name:Dana-Farber Cancer Institute
      address:
         name:Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, USA
         type:PostalAddress
      name:Dana-Farber Cancer Institute
      address:
         name:Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, USA
         type:PostalAddress
      name:Dana-Farber Cancer Institute
      address:
         name:Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, USA
         type:PostalAddress
      name:Dana-Farber Cancer Institute
      address:
         name:Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, USA
         type:PostalAddress
ImageObject:
      url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
Person:
      name:J Chen
      affiliation:
            name:Dana-Farber Cancer Institute
            address:
               name:Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, USA
               type:PostalAddress
            type:Organization
      name:N Imanaka
      affiliation:
            name:Dana-Farber Cancer Institute
            address:
               name:Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, USA
               type:PostalAddress
            type:Organization
      name:J Chen
      affiliation:
            name:Dana-Farber Cancer Institute
            address:
               name:Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, USA
               type:PostalAddress
            type:Organization
      name:J D Griffin
      affiliation:
            name:Dana-Farber Cancer Institute
            address:
               name:Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, USA
               type:PostalAddress
            type:Organization
      email:[email protected]
PostalAddress:
      name:Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, USA
      name:Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, USA
      name:Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, USA
      name:Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, USA

Social Networks {👍}(1)

External Links {🔗}(237)

Analytics and Tracking {📊}

  • Google Tag Manager

Libraries {📚}

  • Prism.js
  • Zoom.js

Emails and Hosting {✉️}

Mail Servers:

  • mx.zoho.eu
  • mx2.zoho.eu
  • mx3.zoho.eu

Name Servers:

  • josh.ns.cloudflare.com
  • zita.ns.cloudflare.com

CDN Services {📦}

  • Crossref

5.2s.